NATCO

OmniLife Health’s Clinical Workflow Automation Platform Enhances Capabilities Within Organ Transplant, Expands into Complex Healthcare Environments

Retrieved on: 
Thursday, January 19, 2023

OmniLife Health , a leader in clinical workflow automation enabling healthcare teams to improve outcomes, enhance efficiencies, reduce costs and improve revenue capture, has expanded its FlowHawk™ platform into additional complex healthcare environments.

Key Points: 
  • OmniLife Health , a leader in clinical workflow automation enabling healthcare teams to improve outcomes, enhance efficiencies, reduce costs and improve revenue capture, has expanded its FlowHawk™ platform into additional complex healthcare environments.
  • FlowHawk’s expansion is timely; a Becker’s Healthcare survey commissioned by OmniLife Health showed adoption of clinical workflow automation software is on track to double from 2022 to 2024.
  • “Demand for communication-centric clinical workflow automation is increasing,” said Dalton Shaull, co-founder and CEO, OmniLife Health.
  • To date, OmniLife has facilitated more than 10,000 transplants cases and continues to expand its platform to support other areas of complex care.

Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited

Retrieved on: 
Wednesday, January 4, 2023

Weiguang Yang, Chairman and Chief Executive Officer of Zhongchao, commented, "We are thrilled to announce the cooperation with Natco.

Key Points: 
  • Weiguang Yang, Chairman and Chief Executive Officer of Zhongchao, commented, "We are thrilled to announce the cooperation with Natco.
  • Mr. Yang further adds, "Due to compulsory licensing requirement in India, Indian generic drugs have the characteristics of early market penetration and good efficacy.
  • Going forward, Xinjiang Pharmaceutical will continue to expand its drug import and export trade business, and introduce imported drugs based on the demands of Chinese patients and increase drug supply offerings.
  • We have been committed to improving the drug accessibility and affordability for patients but bring in greater social economic benefits."

GRANDVIEW AVIATION PRESIDENT JESSIE NAOR ELECTED TO NATA BOARD OF DIRECTORS

Retrieved on: 
Friday, June 17, 2022

BALTIMORE, June 18, 2022 /PRNewswire/ -- At the National Air Transportation Association (NATA) Annual Meeting of the Membership held June 16, 2022, in conjunction with its Aviation Leadership Conference in Washington, DC, Jessie Naor, GrandView Aviation President joined two others as newly elected members of the association's Board of Directors.

Key Points: 
  • BALTIMORE, June 18, 2022 /PRNewswire/ -- At the National Air Transportation Association (NATA) Annual Meeting of the Membership held June 16, 2022, in conjunction with its Aviation Leadership Conference in Washington, DC, Jessie Naor, GrandView Aviation President joined two others as newly elected members of the association's Board of Directors.
  • GrandView Aviation transports private charter passengers and organ transplant teams to communities without airline services around the country," said Ms. Naor.
  • Jessie Naor was named President of GrandView Aviation in 2022 after serving as its Chief Operating Officer and Chief Marketing Officer.
  • "NATA is thrilled to have Jessie as a strong voice for the Part 135 community on NATA's Board of Directors.